The patient has a large red, blistered area on the left hip.
Which pressure injury stage will be recorded in the patient’s chart?

Choice A rationale:

While providing meticulous oral care and allowing ice chips for dry mouth can promote comfort, it does not address the primary concern of absent bowel sounds.

Ice chips could potentially stimulate bowel activity, but this is not a reliable or recommended method for managing absent bowel sounds in the immediate postoperative period.

It's essential to prioritize actions that assess and address the potential causes of absent bowel sounds, as they can indicate serious complications.

Choice B rationale:

Notifying the surgeon immediately and preparing for emergency surgery is not the appropriate first course of action in this situation.

Emergency surgery would be considered only if there were clear signs of a life-threatening complication, such as bowel perforation or peritonitis.

These complications would typically present with additional symptoms such as severe abdominal pain, fever, and hemodynamic instability.

Absent bowel sounds alone, without other concerning signs, do not warrant immediate surgical intervention.

Choice D rationale:

Allowing the patient to have clear liquids as tolerated is not appropriate when bowel sounds are absent. Introducing oral intake before bowel function has returned can increase the risk of nausea, vomiting, and aspiration.

It's crucial to wait for the return of bowel sounds before initiating oral intake to ensure proper digestion and minimize complications.

Choice C rationale:

Keeping the patient NPO (nothing by mouth) is the most appropriate action when bowel sounds are absent after major abdominal surgery.

This allows the bowel to rest and recover from the surgical manipulation.

It also prevents potential complications such as aspiration and nausea/vomiting that could arise from premature oral intake.

Documenting the absence of bowel sounds in the patient's medical record is essential for communication among healthcare providers and for monitoring the patient's progress.

This documentation provides a clear record of the patient's clinical status and facilitates appropriate decision-making regarding further interventions.

Rationale for Choice A:

Mixing insulin detemir and insulin aspart in the same syringe is not recommended due to their differing physicochemical properties and potential for altered absorption and action profiles.

It's crucial to follow manufacturer guidelines, as mixing may lead to suboptimal glycemic control or unpredictable insulin activity.

Rationale for Choice B:

The order of mixing insulin detemir and insulin aspart, even if done incorrectly in the same syringe, would not significantly impact the overall contraindication of mixing them.

The primary concern remains the potential for altered pharmacodynamics and pharmacokinetics when these insulins are combined.

Rationale for Choice C:

Drawing up insulin aspart and insulin detemir in separate syringes is the correct procedure.

This approach ensures that each insulin maintains its intended action profile and absorption characteristics, leading to more predictable glycemic control.

It also aligns with best practices and guidelines for insulin administration.

Rationale for Choice D:

While drawing up insulin detemir first in a separate syringe is technically correct, it offers no specific advantage over drawing up insulin aspart first in a separate syringe.

The key principle is to avoid mixing the two insulins in the same syringe.